Oncolyze, Inc.

Private

New York City, New YorkHealthcare & Life Scienceshttps://oncolyze.com/

Last Round

Series A

Aug 4, 2022

Est. Valuation

$30M

Total Funding Raised

$300,000

Company Overview

Oncolyze, Inc. is a biotechnology company developing novel biotherapeutics for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryoncologypeptide therapeuticsbiotechtargeted therapypreclinical researchdrug developmentinvestigational new drugINDorphan drugbiopharmatherapeutic pipelinedrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncolyze, Inc. Comps

Public and private peers based on sector, stage, and business model.

Oncolyze, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Oncolyze, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Aug 4, 2022
Seed	Jan 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Steve Evans

CEO and Acting Chair

Executive Team

Alex Stojanovic

Fractional COO

Executive Team

Oncolyze, Inc. Investors

Notable investors and investment history

Oncolyze, Inc. investors
Investor	Rounds
The Naissos Group	Seed

View all Investors

Oncolyze, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Oncolyze, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Oncolyze, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Employee Range5

Year Founded2011

Last FundingAug 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.